The Cigna Group (NYSE:CI) Shares Sold by Measured Wealth Private Client Group LLC

Measured Wealth Private Client Group LLC reduced its position in The Cigna Group (NYSE:CI) by 24.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,291 shares of the health services provider’s stock after selling 423 shares during the quarter. Measured Wealth Private Client Group LLC’s holdings in The Cigna Group were worth $469,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CI. Capital Asset Advisory Services LLC increased its holdings in shares of The Cigna Group by 2.3% in the first quarter. Capital Asset Advisory Services LLC now owns 1,280 shares of the health services provider’s stock valued at $464,000 after purchasing an additional 29 shares during the last quarter. Capital Advisors Ltd. LLC raised its holdings in shares of The Cigna Group by 10.6% during the 1st quarter. Capital Advisors Ltd. LLC now owns 335 shares of the health services provider’s stock worth $122,000 after acquiring an additional 32 shares during the period. First Financial Corp IN increased its position in The Cigna Group by 17.2% during the first quarter. First Financial Corp IN now owns 225 shares of the health services provider’s stock worth $82,000 after purchasing an additional 33 shares during the last quarter. Somerset Trust Co raised its stake in The Cigna Group by 1.6% during the first quarter. Somerset Trust Co now owns 2,209 shares of the health services provider’s stock worth $802,000 after purchasing an additional 34 shares during the period. Finally, Relyea Zuckerberg Hanson LLC grew its stake in shares of The Cigna Group by 3.2% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock valued at $333,000 after buying an additional 35 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of several research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research note on Wednesday, June 12th. Robert W. Baird assumed coverage on The Cigna Group in a report on Thursday, May 30th. They set an “outperform” rating and a $388.00 target price for the company. JPMorgan Chase & Co. raised their price target on shares of The Cigna Group from $432.00 to $435.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Barclays began coverage on The Cigna Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price objective on the stock. Finally, StockNews.com cut The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 12th. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, The Cigna Group presently has a consensus rating of “Buy” and a consensus target price of $376.20.

The Cigna Group Price Performance

Shares of NYSE CI traded down $0.36 during trading on Tuesday, hitting $325.91. 1,055,980 shares of the company were exchanged, compared to its average volume of 1,616,527. The firm’s fifty day moving average price is $340.69 and its 200 day moving average price is $333.60. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.71 and a quick ratio of 0.71. The company has a market cap of $92.58 billion, a price-to-earnings ratio of 26.76, a PEG ratio of 1.01 and a beta of 0.52. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $365.71.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, topping the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business had revenue of $57.25 billion for the quarter, compared to analyst estimates of $56.59 billion. During the same period in the previous year, the firm earned $5.41 EPS. The business’s revenue for the quarter was up 23.2% compared to the same quarter last year. On average, sell-side analysts expect that The Cigna Group will post 28.48 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 20th. Investors of record on Tuesday, June 4th were issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date was Tuesday, June 4th. The Cigna Group’s payout ratio is 45.98%.

Insiders Place Their Bets

In other news, Director Elder Granger sold 547 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total transaction of $181,264.86. Following the completion of the transaction, the director now directly owns 5,471 shares in the company, valued at $1,812,979.98. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other The Cigna Group news, insider Brian C. Evanko sold 4,795 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the sale, the insider now owns 39,923 shares in the company, valued at approximately $13,773,834.23. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Elder Granger sold 547 shares of the firm’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $331.38, for a total transaction of $181,264.86. Following the completion of the transaction, the director now owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The disclosure for this sale can be found here. Insiders have sold 22,988 shares of company stock valued at $7,975,726 over the last quarter. Insiders own 0.70% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.